Press Release: Proteros : Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement
Screening identifies several unique compound series that inhibit the SARS-CoV-2 nsp5 main protease, a validated target for the treatment of COVID-19 and potential future coronavirus outbreaks
Read full article »
Proteros is a Germany-based CRO that provides services such as drug discovery and biophysical testing for sectors including biotechnology and pharmaceuticals.
Read more